Patents by Inventor Harold Gregory

Harold Gregory has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Duodenal and gastric ulcer treatment with oral urogastrone
    Patent number: 4820690
    Abstract: Pharmaceutical compositions for oral administration comprise human urogastrone or a urogastrone fragment as active ingredient and such an active ingredient may be used for the manufacture of a medicament for promoting healing of a damaged alimentary tract.
    Type: Grant
    Filed: July 2, 1987
    Date of Patent: April 11, 1989
    Assignee: G. D. Searle & Co.
    Inventors: Harold Gregory, Keith G. McCullagh
  • Urogastrone
    Patent number: 4731357
    Abstract: The use of human urogastrone or a human urogastrone fragment for the manufacture of a medicament for promoting bone and/or tendon repair is described. The medicament is adapted for topical or parenteral administration and is preferably administered directly to the site of the wound or to a site in close proximity thereto.
    Type: Grant
    Filed: March 26, 1986
    Date of Patent: March 15, 1988
    Assignee: Imperial Chemical Industries PLC
    Inventors: Trevor J. Franklin, Harold Gregory, William P. Morris
  • Polypeptides
    Patent number: 4035485
    Abstract: A polypeptide having 46 amino-acid residues and obtained by enzymic degradation of urogastrone. The polypeptide is a potent inhibitor of the secretion of acidic gastric juice.
    Type: Grant
    Filed: August 18, 1975
    Date of Patent: July 12, 1977
    Assignee: Imperial Chemical Industries Limited
    Inventors: Harold Gregory, Beryl Margaret Preston
  • Polypeptides
    Patent number: 4032633
    Abstract: A polypeptide having 47 amino-acid residues which is obtained by enzymic degradation of urogastrone. The polypeptide obtained is a potent inhibitor of the secretion of acidic gastric juice and is of value in the treatment of duodenal ulcers.
    Type: Grant
    Filed: August 18, 1975
    Date of Patent: June 28, 1977
    Assignee: Imperial Chemical Industries Limited
    Inventors: Harold Gregory, Beryl Margaret Preston
  • Polypeptides
    Patent number: 3989821
    Abstract: The modification of porcine or bovine insulin by treatment with a lysine specific amino-endopeptidase, which has the effect of removing L-lysyl-L-alanine from the B chain of the insulin. The products obtained have full insulin-like activity but are less antigenic.
    Type: Grant
    Filed: April 30, 1975
    Date of Patent: November 2, 1976
    Assignee: Imperial Chemical Industries Limited
    Inventors: Harold Gregory, Peter Leslie Walton